Celecoxib improves disease-free and overall survival in ctDNA-positive stage III colon cancer patients when combined with standard chemotherapy. An analysis of patients with stage III colon patients ...

Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival ...

Postoperative circulating tumor DNA (ctDNA) positivity strongly predicts worse survival in stage III colon cancer, with ctDNA-positive patients showing sixfold higher recurrence risk. Among ...

A blood test could help doctors decide which patients with colon cancer should receive anti-inflammatory medication along ...

James Van Der Beek is feeling grateful despite a tough year. The actor, 48, sat down with Craig Melvin for an interview on ...

He was still in an anesthesia-induced haze when his doctor confirmed to him that he had stage 3 colorectal cancer. Shortly ...

This dual-immunotherapy neoadjuvant treatment regimen is mainly intended for patients with resectable stage IIB to III colon ...

James Van Der Beek’s stage 3 colorectal cancer fight will be documented in an upcoming interview on the “Today” show. “Today” ...

Colon cancer is becoming increasingly prevalent among people under the age of 50. However, a recent study also found that 82% of young colon cancer patients were misdiagnosed initially. This also ...